Molecular Partners AG
SWX:MOLN
CHF 3.31
CHF-0.11 (-3.22%)
CHF 3.31
CHF-0.11 (-3.22%)
End-of-day quote: 05/17/2024

Molecular Partners financials at a glance

The revenue of Molecular Partners is reported as 0.1896 billion Switzerland Francs in the fiscal year 2023. The earnings were 3.54 Switzerland Francs per share in 2023, which was 271.84 higher than 2021. And about 0.11806 billion Switzerland Francs are reported as free cash flow in the financials of Molecular Partners 2023. No dividends were paid to the shareholders of the Molecular Partners stock SWX:MOLN in the financial year 2023.

CHF189.60M
Revenue
CHF3.54
Earnings Per Share
73.23%
Gross Margin %
CHF117.39M
Free Cash Flow
Revenue
189.60
Earnings Per Share
3.54
Gross Margin %
73.23
Free Cash Flow
117.39

Financials

Year Year TTM 2022 2021 2020 2019 2018 2017 2016 2015 2014
Rev. Revenue N/A CHF189.60M CHF9.75M CHF9.30M CHF20.40M CHF10.40M CHF20.00M CHF23.00M CHF29.10M CHF26.60M
GM % Gross Margin % 0.00% 73.23% 0.00% 100.00% -,113.40% -,268.93% -87.12% -52.71% 14.07% 77.35%
OM Operating Margin 0.00% 61.50% 0.00% 0.00% -,179.86% 0.00% -,129.12% -84.57% -7.62% 6.91%
EPS Earnings Per Share CHF-1.83 CHF3.54 CHF-2.06 CHF-2.51 CHF-1.72 CHF-1.75 CHF-1.22 CHF-0.91 CHF-0.01 CHF-0.15
Div. Dividends N/A CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00
PR % Payout Ratio % 0 0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%
Sha. Shares N/AM 32.54M 32.15M 29.15M 21.6M 21.23M 21.04M 20.72M 19.58M 19.49M
OCF Operating Cash Flow N/A CHF118.57M CHF-90.95M CHF-28.98M CHF-1.19M CHF-42.50M CHF-40.00M CHF-35.40M CHF26.50M CHF-11.30M
FCF Free Cash Flow N/A CHF117.39M CHF-91.89M CHF-30.43M CHF-2.22M CHF-42.93M CHF-40.50M CHF-36.41M CHF25.13M CHF-11.84M
FCFS Free Cash Flow Per Share CHF-1.79 CHF3.61 CHF-2.98 CHF-1.23 CHF-0.14 CHF-2.05 CHF-1.94 CHF-1.79 CHF1.28 CHF-0.78